In May 2013 GSK and Save the Children announced an ambitious partnership to help save the lives of 1 million children in some of the world’s poorest countries. At the heart of the partnership, from the beginning, has been a recognition that moving beyond the traditional corporate-charity model to a new collaborative approach that fully combines each organisation’s skills, expertise and resources could lead to greater lasting impact. Over the past three years, GSK and Save the Children’s partnership has grown in scope and scale and continues to evolve and innovate. Integrated teams now work at the global and local level on a range of activities including training and supporting health workers, widening vaccination coverage, developing child friendly medicines, researching innovative solutions for life threatening yet preventable conditions, and working to call for stronger child health policies.
As the partnership reached its third anniversary, this Challenge reflected on how two large and diverse organisations have tackled the challenge of translating a shared global commitment into sustained and effective action for children. At a time when the newly adopted Sustainable Development Goals (SDGs) have re-focused attention on the critical role that partnerships will play in delivering ambitious new global development priorities, the Challenge aims to shed new light on partnership practice.
9 months, ending Q1 2017